Brief: Cingulate Inc Reports Fourth Quarter And Full Year 2021 Results And Provides Clinical And Business Update
March 10 (Reuters) - Cingulate Inc CING.O :
* CINGULATE INC. REPORTS FOURTH QUARTER AND FULL YEAR 2021
RESULTS AND PROVIDES CLINICAL AND BUSINESS UPDATE
* CINGULATE - EXPECTS CASH AND CASH EQUIVALENTS AS OF DEC
31, 2021
WILL ENABLE TO FUND RESEARCH AND DEVELOPMENT, EXPENDITURES
THROUGH LATE 2022
* CINGULATE INC QTRLY LOSS PER SHARE $0.32
Source text for Eikon: ID:nGNX6K58XS
Further company coverage: CING.O
Recent news on Cingulate
See all newsBrief: Cingulate Announces Publication Of Phase 3 Adhd Trial Results In Journal Of Child And Adolescent Psychopharmacology
NASDAQ RESUMED AT 09:39 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:34 AM
NASDAQ RESUMED AT 08:30 AM
FDA declines to approve Cingulate's ADHD treatment over manufacturing issues (updated)